Species differences in the effects of leukotriene D4 on inositol trisphosphate accumulation, cyclic AMP formation and contraction in iris sphincter of the mammalian eye.
The effects of leukotriene (LT) D4 on inositol trisphosphate (IP3) accumulation, cAMP formation, and contraction in the iris sphincter smooth muscle of different mammalian species were investigated and functional and biochemical reciprocal interactions between the IP3-Ca2+ and cAMP second messenger systems were demonstrated. The effects of the LT on the biochemical and pharmacological responses are dose- and time-dependent, and are not mediated through the release of acetylcholine or prostaglandins. Addition of LTD4 (0.1-1 microM) to cat and bovine iris sphincters increased IP3 accumulation by 60% of that of the control and induced muscle contraction (the EC50 value for the contractile response in the cat sphincter was 4.8 x 10(-9) M), but had no effect on cAMP formation in these species. In contrast, addition of LTD4 to dog, human, pig, and rabbit sphincters increased cAMP formation by 53-61% of their respective controls, but had no effect on IP3 accumulation and on the contractile state. The rates of formation of LTs in iris sphincters of the different species were found to increase in the following order: bovine less than cat less than human less than dog less than pig less than rabbit. This could suggest that desensitization of LT receptors may in part underlie the species differences observed in the effects of LTD4. We suggest that LTD4 may be involved in regulation of contraction and relaxation in the iris sphincter by increasing IP3 accumulation and consequently Ca2+ mobilization and muscle contraction, and by elevating the level of cAMP which in turn may be involved in the regulation of muscle tension.
Yousufzai
S Y
SY
Department of Cell and Molecular, Medical College of Georgia, Augusta 30912-2100.
Tachado
S D
SD
Abdel-Latif
A A
AA
D000818:Animals; D002415:Cats; D002417:Cattle; D000242:Cyclic AMP / Q000096:biosynthesis* / Q000378:metabolism; D015237:Dinoprost / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D007294:Inositol / Q000378:metabolism; D015544:Inositol 1,4,5-Trisphosphate / Q000378:metabolism*; D007498:Iris / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D011817:Rabbits; D011863:Radioimmunoassay; D013189:SRS-A / Q000494:pharmacology*; D013045:Species Specificity; D013552:Swine
D013189:SRS-A; D007294:Inositol; D015544:Inositol 1,4,5-Trisphosphate; D015237:Dinoprost; D000242:Cyclic AMP